The Pistoia Alliance and quattro research are pleased to announce the release of an extension to the HELM biomolecular representation standard.
In June 2014, Richard will join the Pistoia Alliance as Executive Director of Operations to continue the Pistoia Alliance’s recent success in providing innovative solutions to common problems in life science R&D.
The March 2014 edition of the Pistoia Alliance newsletter, Innovation in Action, is available to download as a PDF document.
The Pistoia Alliance Controlled Substance Compliance Services Project Successfully Passes the First Phase of Industry Testing
Controlled Substance legislation is complex and ever changing. As such, it requires on-going and detailed interpretation to identify those compounds that are within scope of regional and international laws.
Lowering Barriers to R&D Innovation
We are a global, not-for-profit alliance of life science companies, vendors, publishers, and academic groups that work together to lower barriers to innovation in R&D.
Our projects transform R&D innovation through pre-competitive collaboration. We bring together the key constituents to identify the root causes that lead to R&D inefficiencies. We develop best practices and technology pilots to overcome common obstacles.
Our members collaborate as equals on open projects that generate significant value for the worldwide life sciences community.
With the launch of our Interactive Project Portfolio Platform (IP3) we are embracing a new level of openness, access, and transparency around our idea-to-project process. The platform is open to the public to submit new ideas, comment and vote on proposed ideas, and monitor the progress of our projects.
The Pistoia Alliance are delighted to announce an exciting additional award for the 2016 President’s Challenge from Thomson Reuters.
The Pistoia Alliance, an organization dedicated to improving global life sciences R&D, has seen its membership increase with a number of new members including both large multinationals and start-ups.